Difference between revisions of "CD10"

From Libre Pathology
Jump to navigation Jump to search
Line 5: Line 5:
*Benign liver.<ref name=pmid14755758/>
*Benign liver.<ref name=pmid14755758/>
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal  | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref>
===Lymphoma===
*[[Follicular lymphoma]].
*[[Diffuse large B-cell lymphoma]].
*[[Diffuse large B-cell lymphoma]].



Revision as of 17:35, 20 March 2015

CD10 is a commonly used immunostain.

Positive

Lymphoma

See also

References

  1. 1.0 1.1 Lin, F.; Abdallah, H.; Meschter, S. (Feb 2004). "Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.". Diagn Cytopathol 30 (2): 92-7. doi:10.1002/dc.10419. PMID 14755758.